LEVETIRACETAM ORAL

LEVETIRACETAM ORAL was reported 78637 times

LEVETIRACETAM ORAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEW ONSET REFRACTORY STATUS EPILEPTICUS 57 0.5182
1 TUBEROUS SCLEROSIS COMPLEX 49 0.4667
2 POSTICTAL PSYCHOSIS 71 0.4551
3 EPILEPTIC ENCEPHALOPATHY 94 0.4215
4 MULTIPLE-DRUG RESISTANCE 1307 0.4211
5 PSYCHOGENIC SEIZURE 259 0.2770
6 CHANGE IN SEIZURE PRESENTATION 175 0.2705
7 FOCAL DYSCOGNITIVE SEIZURES 304 0.2669
8 ANTICOAGULATION DRUG LEVEL ABNORMAL 39 0.2617
9 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 122 0.2607
10 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 135 0.2523
11 POSTICTAL PARALYSIS 50 0.2066
12 MYOCLONIC EPILEPSY 303 0.1996
13 STATUS EPILEPTICUS 2102 0.1859
14 PARTIAL SEIZURES 938 0.1789
15 LENNOX-GASTAUT SYNDROME 39 0.1718
16 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 110 0.1692
17 SEIZURE CLUSTER 132 0.1592
18 SIMPLE PARTIAL SEIZURES 120 0.1487
19 DEJA VU 40 0.1455
20 TEMPORAL LOBE EPILEPSY 63 0.1442
21 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 54 0.1421
22 ATONIC SEIZURES 122 0.1420
23 INFANTILE SPASMS 101 0.1397
24 PETIT MAL EPILEPSY 661 0.1293
25 PROPOFOL INFUSION SYNDROME 90 0.1277
26 VAGAL NERVE STIMULATOR IMPLANTATION 39 0.1275
27 TONIC CONVULSION 178 0.1255
28 GENERALISED TONIC-CLONIC SEIZURE 2051 0.1238
29 ANTICONVULSANT DRUG LEVEL DECREASED 174 0.1231
30 TOXIC OPTIC NEUROPATHY 49 0.1129
31 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 84 0.1116
32 BRAIN MALFORMATION 39 0.1092
33 DEVELOPMENTAL HIP DYSPLASIA 90 0.1082
34 TRISOMY 18 40 0.1050
35 AURA 189 0.1012
36 ANTICONVULSANT DRUG LEVEL INCREASED 160 0.0990
37 NECROSIS ISCHAEMIC 45 0.0976
38 HYPERAMMONAEMIC ENCEPHALOPATHY 166 0.0954
39 EPILEPSY 2826 0.0924
40 POLYDACTYLY 107 0.0922
41 ENCEPHALITIS AUTOIMMUNE 119 0.0905
42 CRYPTORCHISM 95 0.0846
43 COMPLEX PARTIAL SEIZURES 94 0.0845
44 BEHAVIOUR DISORDER 449 0.0829
45 PLEOCYTOSIS 47 0.0808
46 CLONIC CONVULSION 59 0.0806
47 ANENCEPHALY 44 0.0779
48 SEIZURE 8983 0.0777
49 FOETAL MALFORMATION 83 0.0764
50 ELECTROENCEPHALOGRAM ABNORMAL 240 0.0759
51 PARADOXICAL DRUG REACTION 276 0.0749
52 EXOMPHALOS 39 0.0726
53 SELECTIVE EATING DISORDER 66 0.0725
54 DRUG WITHDRAWAL CONVULSIONS 128 0.0719
55 INTELLECTUAL DISABILITY 108 0.0711
56 STILLBIRTH 331 0.0684
57 ACIDOSIS HYPERCHLORAEMIC 39 0.0657
58 HYPERAMMONAEMIA 312 0.0623
59 CYTOGENETIC ABNORMALITY 68 0.0602
60 SYNDACTYLY 49 0.0590
61 BRADYCARDIA NEONATAL 74 0.0588
62 KETOSIS 63 0.0581
63 HYPOSPADIAS 120 0.0576
64 BREAST FEEDING 45 0.0576
65 SPINA BIFIDA 119 0.0571
66 GLIOBLASTOMA MULTIFORME 48 0.0570
67 FEBRILE CONVULSION 69 0.0566
68 PYLORIC STENOSIS 47 0.0555
69 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 36 0.0555
70 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 120 0.0536
71 CONGENITAL HYDRONEPHROSIS 38 0.0531
72 CEREBELLAR ATROPHY 46 0.0522
73 CEREBELLAR ATAXIA 49 0.0511
74 TRISOMY 21 64 0.0508
75 HEMIANOPIA 50 0.0504
76 INFANTILE APNOEA 41 0.0502
77 DYSMORPHISM 116 0.0492
78 CLEFT PALATE 95 0.0491
79 NEUROPSYCHIATRIC SYMPTOMS 44 0.0487
80 APLASTIC ANAEMIA 250 0.0478
81 RESPIRATORY DISORDER NEONATAL 77 0.0475
82 EXCESSIVE EYE BLINKING 70 0.0473
83 CONGENITAL ANOMALY 363 0.0468
84 CLEFT LIP AND PALATE 52 0.0465
85 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 273 0.0460
86 VANISHING BILE DUCT SYNDROME 50 0.0448
87 SMALL FOR DATES BABY 222 0.0447
88 ATAXIA 530 0.0446
89 GLIOBLASTOMA 76 0.0445
90 POSTICTAL STATE 46 0.0443
91 HYDROCELE 46 0.0432
92 MYOCLONUS 513 0.0430
93 ASTERIXIS 44 0.0414
94 WHITE MATTER LESION 52 0.0411
95 GAZE PALSY 70 0.0411
96 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 109 0.0409
97 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1053 0.0409
98 HYPOTONIA NEONATAL 63 0.0403
99 ABORTION SPONTANEOUS 1596 0.0398
100 WRONG PATIENT RECEIVED PRODUCT 114 0.0389
101 NEUROLOGICAL DECOMPENSATION 89 0.0384
102 ACUTE PSYCHOSIS 94 0.0380
103 TALIPES 118 0.0380
104 VENTRICULAR SEPTAL DEFECT 216 0.0377
105 BRAIN OPERATION 84 0.0368
106 MATERNAL EXPOSURE DURING PREGNANCY 3194 0.0358
107 CHOLESTATIC LIVER INJURY 78 0.0350
108 SYSTEMIC INFECTION 58 0.0350
109 PATENT DUCTUS ARTERIOSUS 137 0.0345
110 LOW BIRTH WEIGHT BABY 273 0.0343
111 MATERNAL EXPOSURE DURING BREAST FEEDING 137 0.0337
112 TOXIC ENCEPHALOPATHY 171 0.0337
113 DRUG RESISTANCE 862 0.0335
114 NECROTISING COLITIS 42 0.0331
115 FANCONI SYNDROME 46 0.0325
116 FOETAL EXPOSURE DURING PREGNANCY 2642 0.0325
117 MICROCEPHALY 41 0.0320
118 ATRIAL SEPTAL DEFECT 261 0.0311
119 MUTISM 45 0.0310
120 PREGNANCY 620 0.0309
121 PSYCHOMOTOR SKILLS IMPAIRED 81 0.0309
122 EXPOSURE VIA BREAST MILK 123 0.0309
123 GRAND MAL CONVULSION 283 0.0306
124 SINUS NODE DYSFUNCTION 56 0.0306
125 RHABDOMYOLYSIS 1222 0.0293
126 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 270 0.0283
127 TOXIC EPIDERMAL NECROLYSIS 428 0.0282
128 DEATH NEONATAL 39 0.0280
129 ENCEPHALOPATHY 683 0.0278
130 TONIC CLONIC MOVEMENTS 36 0.0277
131 NYSTAGMUS 147 0.0277
132 VASOPLEGIA SYNDROME 45 0.0274
133 ABORTION INDUCED 257 0.0273
134 MATERNAL EXPOSURE BEFORE PREGNANCY 186 0.0272
135 QUADRIPARESIS 45 0.0271
136 ACCIDENTAL DEATH 50 0.0269
137 PERSECUTORY DELUSION 67 0.0268
138 CEREBRAL ATROPHY 105 0.0263
139 CYTOKINE RELEASE SYNDROME 526 0.0262
140 AGGRESSION 1296 0.0259
141 GINGIVAL HYPERTROPHY 39 0.0257
142 HYPERNATRAEMIA 126 0.0253
143 AUTONOMIC NERVOUS SYSTEM IMBALANCE 73 0.0250
144 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 128 0.0249
145 PSYCHOMOTOR RETARDATION 70 0.0249
146 RESPIRATORY ACIDOSIS 97 0.0247
147 POTENTIATING DRUG INTERACTION 82 0.0244
148 STUPOR 78 0.0243
149 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 181 0.0241
150 STARING 57 0.0236
151 ENDOTRACHEAL INTUBATION 65 0.0232
152 LANGUAGE DISORDER 50 0.0231
153 METABOLIC ENCEPHALOPATHY 69 0.0230
154 CONVULSION 1278 0.0223
155 DEPRESSIVE SYMPTOM 78 0.0221
156 DIABETES INSIPIDUS 53 0.0220
157 BRADYARRHYTHMIA 36 0.0219
158 RASH MORBILLIFORM 60 0.0216
159 FOETAL GROWTH RESTRICTION 131 0.0215
160 PARAPLEGIA 62 0.0215
161 APLASIA 42 0.0214
162 TONGUE BITING 44 0.0213
163 AMMONIA INCREASED 108 0.0211
164 PARKINSONISM 206 0.0211
165 BRAIN HERNIATION 63 0.0211
166 OCULOGYRIC CRISIS 45 0.0209
167 DRUG DOSE TITRATION NOT PERFORMED 38 0.0207
168 SUICIDAL BEHAVIOUR 86 0.0207
169 HYPERTRANSAMINASAEMIA 143 0.0205
170 BRAIN OEDEMA 259 0.0205
171 PREMATURE DELIVERY 325 0.0204
172 DRUG LEVEL INCREASED 331 0.0200
173 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 76 0.0199
174 AFFECTIVE DISORDER 156 0.0198
175 DRUG LEVEL DECREASED 200 0.0196
176 DISORGANISED SPEECH 36 0.0195
177 IMPULSIVE BEHAVIOUR 73 0.0194
178 DEVELOPMENTAL DELAY 175 0.0194
179 MENINGITIS ASEPTIC 87 0.0194
180 CLONUS 52 0.0190
181 STEVENS-JOHNSON SYNDROME 419 0.0188
182 HYPOMAGNESAEMIA 260 0.0187
183 HYDROCEPHALUS 101 0.0185
184 IMPULSE-CONTROL DISORDER 38 0.0184
185 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1013 0.0184
186 PSYCHOTIC SYMPTOM 38 0.0184
187 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 143 0.0184
188 FOETAL DISTRESS SYNDROME 39 0.0184
189 GENE MUTATION 36 0.0182
190 BRAIN ABSCESS 46 0.0182
191 TEMPERATURE REGULATION DISORDER 40 0.0179
192 EYE MOVEMENT DISORDER 122 0.0178
193 HYPOVENTILATION 58 0.0178
194 PRODUCT PACKAGING CONFUSION 43 0.0177
195 PSYCHIATRIC SYMPTOM 130 0.0176
196 APNOEA 137 0.0176
197 COGNITIVE DISORDER 814 0.0174
198 METASTATIC MALIGNANT MELANOMA 40 0.0174
199 PSYCHOTIC DISORDER 514 0.0174
200 ALTERED STATE OF CONSCIOUSNESS 372 0.0172
201 ANGER 578 0.0171
202 TORSADE DE POINTES 134 0.0171
203 PARESIS 38 0.0170
204 BRADYPNOEA 46 0.0170
205 ACUTE HEPATIC FAILURE 232 0.0170
206 ENCEPHALITIS 117 0.0169
207 ATRIOVENTRICULAR BLOCK COMPLETE 113 0.0169
208 DRUG LEVEL BELOW THERAPEUTIC 93 0.0168
209 PRE-ECLAMPSIA 80 0.0168
210 EXPOSURE DURING PREGNANCY 1044 0.0168
211 GRAFT VERSUS HOST DISEASE IN SKIN 37 0.0168
212 PERSONALITY CHANGE 156 0.0168
213 METABOLIC ACIDOSIS 533 0.0167
214 NEUROTOXICITY 292 0.0166
215 TUBULOINTERSTITIAL NEPHRITIS 307 0.0164
216 EOSINOPHILIA 285 0.0162
217 PNEUMONIA ASPIRATION 406 0.0162
218 MULTIPLE ORGAN DYSFUNCTION SYNDROME 458 0.0162
219 HAEMODYNAMIC INSTABILITY 123 0.0161
220 HOSTILITY 41 0.0161
221 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 42 0.0160
222 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 52 0.0160
223 DRUG INTERACTION 2533 0.0160
224 MENTAL STATUS CHANGES 440 0.0158
225 APHASIA 473 0.0156
226 HALLUCINATION, AUDITORY 247 0.0155
227 IRRITABILITY 931 0.0155
228 AFFECT LABILITY 148 0.0154
229 PSYCHOMOTOR HYPERACTIVITY 255 0.0153
230 PERSONALITY DISORDER 40 0.0153
231 BLOOD LACTIC ACID INCREASED 80 0.0152
232 SYSTEMIC CANDIDA 38 0.0151
233 DELIRIUM 525 0.0151
234 INTESTINAL ISCHAEMIA 83 0.0151
235 DELUSION 233 0.0150
236 MIXED LIVER INJURY 45 0.0149
237 LEARNING DISORDER 36 0.0149
238 PREMATURE BABY 447 0.0148
239 HYPOTONIA 148 0.0148
240 LIVER ABSCESS 48 0.0148
241 MATERNAL DRUGS AFFECTING FOETUS 113 0.0147
242 HALLUCINATION, VISUAL 311 0.0147
243 HYPERCAPNIA 44 0.0146
244 COORDINATION ABNORMAL 202 0.0145
245 DEPRESSED LEVEL OF CONSCIOUSNESS 572 0.0144
246 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 148 0.0144
247 GUILLAIN-BARRE SYNDROME 69 0.0143
248 CARDIOPULMONARY FAILURE 55 0.0141
249 VENOOCCLUSIVE LIVER DISEASE 69 0.0140
250 SEDATION 365 0.0139
251 BRADYPHRENIA 90 0.0138
252 ATRIOVENTRICULAR BLOCK FIRST DEGREE 59 0.0136
253 BRAIN NEOPLASM 125 0.0136
254 ABNORMAL BEHAVIOUR 539 0.0136
255 MALABSORPTION 71 0.0136
256 HEMIPARESIS 229 0.0135
257 VENTRICULAR FIBRILLATION 150 0.0135
258 AGITATION 987 0.0134
259 HEPATIC CYTOLYSIS 170 0.0133
260 CATATONIA 70 0.0133
261 HALLUCINATIONS, MIXED 56 0.0133
262 HEART DISEASE CONGENITAL 47 0.0133
263 BRAIN DEATH 41 0.0133
264 HYPOTHERMIA 134 0.0132
265 SUSPECTED SUICIDE 62 0.0132
266 CRANIOCEREBRAL INJURY 40 0.0132
267 ATRIOVENTRICULAR BLOCK SECOND DEGREE 40 0.0132
268 MAJOR DEPRESSION 96 0.0131
269 CYTOMEGALOVIRUS INFECTION REACTIVATION 58 0.0131
270 MUCOSAL INFLAMMATION 343 0.0131
271 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 54 0.0130
272 ATTENTION DEFICIT HYPERACTIVITY DISORDER 54 0.0128
273 METASTASES TO CENTRAL NERVOUS SYSTEM 165 0.0128
274 VENTRICULAR TACHYCARDIA 211 0.0128
275 RASH MACULO-PAPULAR 283 0.0127
276 HYPERTHERMIA 97 0.0127
277 POSTURE ABNORMAL 41 0.0126
278 GESTATIONAL DIABETES 60 0.0126
279 HYPONATRAEMIA 702 0.0124
280 FEELING DRUNK 92 0.0124
281 AUTOIMMUNE HEPATITIS 86 0.0124
282 BRADYKINESIA 71 0.0120
283 AUTISM SPECTRUM DISORDER 66 0.0120
284 NORMAL NEWBORN 65 0.0119
285 HEPATOCELLULAR INJURY 169 0.0119
286 MOOD SWINGS 379 0.0119
287 OBSESSIVE-COMPULSIVE DISORDER 95 0.0118
288 THERAPY PARTIAL RESPONDER 184 0.0118
289 THROMBOCYTOSIS 43 0.0117
290 LYMPHOPENIA 165 0.0117
291 PRODUCT SUBSTITUTION ISSUE 668 0.0116
292 NEONATAL RESPIRATORY DISTRESS SYNDROME 41 0.0116
293 ELECTROCARDIOGRAM QT PROLONGED 415 0.0115
294 EXPOSURE DURING BREAST FEEDING 38 0.0115
295 COMMUNICATION DISORDER 43 0.0112
296 TOXICITY TO VARIOUS AGENTS 1890 0.0112
297 PARANOIA 193 0.0112
298 ASPIRATION 122 0.0111
299 HYPOGAMMAGLOBULINAEMIA 73 0.0111
300 SUBDURAL HAEMATOMA 159 0.0111
301 SOPOR 147 0.0111
302 DRUG-INDUCED LIVER INJURY 348 0.0111
303 SINUS BRADYCARDIA 107 0.0111
304 THERAPY NON-RESPONDER 497 0.0110
305 PRIAPISM 38 0.0110
306 SCREAMING 70 0.0110
307 MOOD ALTERED 299 0.0110
308 THROMBOCYTOPENIA 1225 0.0109
309 RESPIRATORY DEPRESSION 134 0.0109
310 DIABETIC NEUROPATHY 54 0.0109
311 ELECTROLYTE IMBALANCE 126 0.0108
312 APATHY 158 0.0108
313 UNRESPONSIVE TO STIMULI 279 0.0108
314 NEUTROPENIC SEPSIS 77 0.0108
315 CHOLESTASIS 207 0.0108
316 LEUKOENCEPHALOPATHY 40 0.0107
317 THINKING ABNORMAL 200 0.0107
318 DRUG ERUPTION 189 0.0107
319 WRONG PRODUCT ADMINISTERED 72 0.0106
320 BLOOD CREATINE PHOSPHOKINASE INCREASED 306 0.0106
321 HYPOKALAEMIA 490 0.0106
322 SOMNOLENCE 2130 0.0106
323 FACIAL BONES FRACTURE 38 0.0105
324 DYSARTHRIA 395 0.0105
325 SELF-INJURIOUS IDEATION 44 0.0105
326 MANIA 171 0.0104
327 DISORIENTATION 410 0.0103
328 HYPERREFLEXIA 36 0.0103
329 CEREBRAL DISORDER 76 0.0103
330 HYPERBILIRUBINAEMIA 106 0.0102
331 FLUID INTAKE REDUCED 51 0.0102
332 CIRCULATORY COLLAPSE 173 0.0101
333 DERMATITIS EXFOLIATIVE GENERALISED 35 0.0101
334 DIPLOPIA 261 0.0100
335 INTENTIONAL OVERDOSE 640 0.0100
336 HOMICIDAL IDEATION 40 0.0099
337 BRADYCARDIA 522 0.0098
338 FOETAL DEATH 51 0.0098
339 PULSELESS ELECTRICAL ACTIVITY 41 0.0098
340 DYSPHEMIA 43 0.0098
341 INTENTIONAL SELF-INJURY 198 0.0098
342 HYPOCALCAEMIA 185 0.0098
343 RESPIRATORY FAILURE 707 0.0097
344 COMA 461 0.0097
345 THROMBOTIC MICROANGIOPATHY 94 0.0096
346 BRAIN NEOPLASM MALIGNANT 43 0.0096
347 HYPERTONIA 55 0.0096
348 CEREBRAL HAEMORRHAGE 343 0.0096
349 SEROTONIN SYNDROME 184 0.0096
350 NEUROLEPTIC MALIGNANT SYNDROME 113 0.0095
351 DYSKINESIA 387 0.0095
352 ENTEROCOCCAL INFECTION 46 0.0095
353 MUSCLE TWITCHING 219 0.0095
354 HEPATITIS CHOLESTATIC 57 0.0095
355 ATRIOVENTRICULAR BLOCK 73 0.0094
356 DISTURBANCE IN ATTENTION 508 0.0094
357 CENTRAL NERVOUS SYSTEM LESION 129 0.0094
358 PETECHIAE 97 0.0093
359 LEUKOCYTOSIS 168 0.0093
360 CARDIOTOXICITY 82 0.0092
361 TREATMENT FAILURE 757 0.0091
362 CACHEXIA 47 0.0091
363 HYPOALBUMINAEMIA 71 0.0091
364 SALIVARY HYPERSECRETION 91 0.0091
365 PRODUCT ADMINISTRATION ERROR 183 0.0090
366 PANCYTOPENIA 506 0.0090
367 TREATMENT NONCOMPLIANCE 495 0.0090
368 HYPERPYREXIA 38 0.0090
369 ILEUS PARALYTIC 40 0.0090
370 CAESAREAN SECTION 104 0.0089
371 MOTOR DYSFUNCTION 91 0.0089
372 CLOSTRIDIUM DIFFICILE COLITIS 94 0.0089
373 MUSCLE RIGIDITY 106 0.0089
374 OLIGURIA 55 0.0089
375 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 78 0.0088
376 HEMIPLEGIA 73 0.0088
377 HEPATITIS ACUTE 57 0.0088
378 ESCHERICHIA URINARY TRACT INFECTION 37 0.0087
379 HEPATIC ENCEPHALOPATHY 81 0.0087
380 HALLUCINATION 653 0.0087
381 TOXIC SKIN ERUPTION 87 0.0086
382 PEMPHIGOID 65 0.0086
383 ERYSIPELAS 43 0.0085
384 RESTLESSNESS 312 0.0085
385 ACUTE RESPIRATORY FAILURE 164 0.0085
386 CARDIAC ARREST 696 0.0084
387 ACUTE KIDNEY INJURY 1290 0.0084
388 LEFT VENTRICULAR HYPERTROPHY 36 0.0084
389 CONFUSIONAL STATE 1351 0.0084
390 SUICIDE ATTEMPT 505 0.0083
391 ACIDOSIS 63 0.0082
392 HAEMORRHAGE INTRACRANIAL 123 0.0082
393 AGRANULOCYTOSIS 152 0.0082
394 ISCHAEMIC STROKE 145 0.0081
395 HEAD INJURY 257 0.0081
396 TRANSAMINASES INCREASED 180 0.0081
397 STRESS CARDIOMYOPATHY 47 0.0081
398 PRESCRIBED OVERDOSE 156 0.0081
399 ERYTHEMA MULTIFORME 75 0.0080
400 SKIN ABRASION 38 0.0080
401 GAMMA-GLUTAMYLTRANSFERASE INCREASED 178 0.0080
402 ENTEROCOLITIS 46 0.0080
403 COAGULOPATHY 132 0.0079
404 HEPATOTOXICITY 176 0.0079
405 VITAMIN D DEFICIENCY 77 0.0079
406 HUMERUS FRACTURE 38 0.0079
407 DRUG LEVEL ABOVE THERAPEUTIC 36 0.0079
408 POLYNEUROPATHY 94 0.0078
409 PRODUCT ODOUR ABNORMAL 81 0.0077
410 CONDITION AGGRAVATED 2341 0.0077
411 LEUKOPENIA 384 0.0077
412 RESPIRATORY RATE INCREASED 68 0.0077
413 REBOUND EFFECT 86 0.0076
414 OFF LABEL USE 6639 0.0076
415 PSEUDOMONAS INFECTION 65 0.0076
416 INCOHERENT 49 0.0076
417 SPEECH DISORDER 396 0.0076
418 KLEBSIELLA INFECTION 38 0.0075
419 PRODUCT TASTE ABNORMAL 101 0.0075
420 RASH PUSTULAR 54 0.0074
421 SINUS TACHYCARDIA 105 0.0074
422 HYPOPHOSPHATAEMIA 54 0.0073
423 SUICIDAL IDEATION 666 0.0073
424 SENSORY LOSS 58 0.0072
425 MENINGITIS 48 0.0072
426 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 59 0.0071
427 HEPATITIS 183 0.0071
428 DYSGRAPHIA 47 0.0071
429 BRAIN INJURY 71 0.0071
430 HYDRONEPHROSIS 53 0.0071
431 HERPES SIMPLEX 46 0.0071
432 INGUINAL HERNIA 43 0.0071
433 RESPIRATORY DISTRESS 195 0.0071
434 HAEMOLYTIC ANAEMIA 63 0.0070
435 CEREBRAL ISCHAEMIA 36 0.0070
436 BIPOLAR DISORDER 76 0.0070
437 DRUG INEFFECTIVE 9213 0.0070
438 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 497 0.0070
439 HEPATIC FUNCTION ABNORMAL 258 0.0069
440 DERMATITIS BULLOUS 50 0.0069
441 DEPRESSED MOOD 364 0.0069
442 HYPOXIA 242 0.0069
443 URINE OUTPUT DECREASED 60 0.0069
444 DYSTONIA 133 0.0069
445 BLOOD ALBUMIN DECREASED 54 0.0068
446 SUBARACHNOID HAEMORRHAGE 69 0.0068
447 EJECTION FRACTION DECREASED 105 0.0067
448 BACTERAEMIA 80 0.0067
449 HYPERSOMNIA 193 0.0067
450 AMNESIA 434 0.0067
451 ENTERITIS 42 0.0066
452 BALANCE DISORDER 565 0.0065
453 DROOLING 45 0.0065
454 PRODUCT PRESCRIBING ERROR 155 0.0065
455 ACUTE RESPIRATORY DISTRESS SYNDROME 115 0.0065
456 SEPTIC SHOCK 280 0.0064
457 INCONTINENCE 68 0.0064
458 LETHARGY 368 0.0064
459 OXYGEN SATURATION DECREASED 359 0.0064
460 MENTAL DISORDER 278 0.0064
461 CYTOMEGALOVIRUS INFECTION 106 0.0064
462 METABOLIC DISORDER 37 0.0064
463 CYTOPENIA 78 0.0064
464 PRESCRIBED UNDERDOSE 127 0.0064
465 JOINT DISLOCATION 67 0.0063
466 FRUSTRATION TOLERANCE DECREASED 51 0.0063
467 NEUROLOGICAL SYMPTOM 36 0.0063
468 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 38 0.0062
469 MENTAL IMPAIRMENT 151 0.0062
470 COMPLETED SUICIDE 517 0.0062
471 DISSEMINATED INTRAVASCULAR COAGULATION 87 0.0062
472 VENTRICULAR EXTRASYSTOLES 64 0.0062
473 URINARY RETENTION 205 0.0061
474 CARDIO-RESPIRATORY ARREST 256 0.0061
475 HOSPICE CARE 60 0.0061
476 MEMORY IMPAIRMENT 833 0.0061
477 TRICUSPID VALVE INCOMPETENCE 48 0.0060
478 TACHYPNOEA 82 0.0060
479 PULMONARY HAEMORRHAGE 47 0.0060
480 ACCIDENTAL OVERDOSE 219 0.0060
481 DIFFUSE LARGE B-CELL LYMPHOMA 46 0.0060
482 LIVER INJURY 146 0.0059
483 AKATHISIA 81 0.0059
484 EOSINOPHIL COUNT INCREASED 49 0.0059
485 PURPURA 52 0.0059
486 BLEPHAROSPASM 37 0.0059
487 CYANOSIS 92 0.0058
488 ECCHYMOSIS 40 0.0058
489 CONCUSSION 45 0.0058
490 PULMONARY TOXICITY 41 0.0058
491 BODY TEMPERATURE DECREASED 57 0.0058
492 GENERAL PHYSICAL HEALTH DETERIORATION 669 0.0058
493 FEBRILE NEUTROPENIA 383 0.0058
494 EPSTEIN-BARR VIRUS INFECTION 36 0.0058
495 HAEMATOMA 149 0.0057
496 MEDICATION ERROR 319 0.0057
497 NERVOUS SYSTEM DISORDER 179 0.0057
498 CARDIOGENIC SHOCK 82 0.0057
499 ATELECTASIS 55 0.0057
500 URINARY INCONTINENCE 168 0.0057
501 SENSORY DISTURBANCE 91 0.0057
502 HYPOTENSION 1136 0.0057
503 DRUG EXPOSURE DURING PREGNANCY 192 0.0056
504 TACHYCARDIA 501 0.0056
505 POLYURIA 46 0.0056
506 DISEASE RECURRENCE 267 0.0056
507 SLEEP DISORDER 396 0.0056
508 FALL 1865 0.0056
509 ALANINE AMINOTRANSFERASE INCREASED 344 0.0056
510 LEFT VENTRICULAR DYSFUNCTION 37 0.0055
511 FACIAL PARALYSIS 47 0.0055
512 TREMOR 910 0.0055
513 HEPATIC FAILURE 165 0.0055
514 FRACTURE 103 0.0054
515 OVERDOSE 1169 0.0054
516 LOSS OF CONSCIOUSNESS 694 0.0054
517 SHOCK HAEMORRHAGIC 44 0.0054
518 SUDDEN DEATH 57 0.0054
519 PARALYSIS 77 0.0054
520 THERMAL BURN 38 0.0053
521 INTESTINAL PERFORATION 60 0.0053
522 LOSS OF LIBIDO 48 0.0053
523 DERMATITIS ALLERGIC 67 0.0053
524 SHOCK 122 0.0053
525 LIVE BIRTH 44 0.0053
526 HICCUPS 43 0.0052
527 SUPRAVENTRICULAR TACHYCARDIA 50 0.0052
528 IRON DEFICIENCY ANAEMIA 48 0.0052
529 POISONING 65 0.0052
530 DYSPHAGIA 491 0.0052
531 PANCREATITIS ACUTE 116 0.0052
532 SKIN LACERATION 56 0.0051
533 MYDRIASIS 66 0.0051
534 SEPSIS 568 0.0051
535 NEUTROPENIA 692 0.0051
536 ILEUS 63 0.0051
537 ORTHOSTATIC HYPOTENSION 88 0.0050
538 BLOOD SODIUM DECREASED 95 0.0050
539 CRYING 183 0.0050
540 HYPERCALCAEMIA 62 0.0050
541 HAEMATEMESIS 127 0.0050
542 RESPIRATORY ARREST 138 0.0050
543 DRUG INTOLERANCE 483 0.0050
544 HAEMORRHAGIC STROKE 39 0.0050
545 LACTIC ACIDOSIS 161 0.0050
546 DISEASE PROGRESSION 588 0.0050
547 MOVEMENT DISORDER 159 0.0049
548 CLOSTRIDIUM DIFFICILE INFECTION 108 0.0049
549 HEPATIC STEATOSIS 92 0.0049
550 DEPRESSION 1121 0.0049
551 PRODUCT AVAILABILITY ISSUE 112 0.0049
552 ASPARTATE AMINOTRANSFERASE INCREASED 261 0.0049
553 GAIT DISTURBANCE 937 0.0049
554 RENAL TUBULAR NECROSIS 48 0.0049
555 ANAL INCONTINENCE 44 0.0049
556 HYPOPHAGIA 125 0.0049
557 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 35 0.0049
558 ADRENAL INSUFFICIENCY 59 0.0049
559 HYPOKINESIA 70 0.0048
560 LYMPHOCYTE COUNT DECREASED 85 0.0048
561 INTENTIONAL PRODUCT MISUSE 420 0.0048
562 DECUBITUS ULCER 39 0.0048
563 CHOLECYSTITIS 57 0.0048
564 HEPATOMEGALY 47 0.0048
565 NO THERAPEUTIC RESPONSE 58 0.0048
566 POISONING DELIBERATE 45 0.0047
567 JAUNDICE 127 0.0047
568 PANIC ATTACK 172 0.0047
569 PNEUMONITIS 128 0.0047
570 LIPASE INCREASED 36 0.0047
571 TRANSFUSION 49 0.0047
572 WOUND INFECTION 51 0.0047
573 PYREXIA 1606 0.0046
574 PHOTOPHOBIA 87 0.0046
575 PERICARDIAL EFFUSION 106 0.0046
576 HYPERTHYROIDISM 66 0.0046
577 POOR QUALITY SLEEP 98 0.0045
578 SKIN REACTION 64 0.0045
579 PRODUCT USE IN UNAPPROVED INDICATION 1123 0.0045
580 PRODUCT USE ISSUE 846 0.0045
581 MALNUTRITION 50 0.0045
582 PNEUMONIA BACTERIAL 41 0.0045
583 NEPHROPATHY TOXIC 50 0.0044
584 SLEEP APNOEA SYNDROME 85 0.0044
585 ADVERSE REACTION 59 0.0044
586 LIVER FUNCTION TEST ABNORMAL 129 0.0044
587 SYNCOPE 443 0.0044
588 MYOPATHY 38 0.0044
589 EUPHORIC MOOD 45 0.0044
590 END STAGE RENAL DISEASE 80 0.0044
591 C-REACTIVE PROTEIN INCREASED 159 0.0044
592 FEEDING DISORDER 88 0.0043
593 CEREBRAL INFARCTION 106 0.0043
594 DEMENTIA 121 0.0043
595 MITRAL VALVE INCOMPETENCE 49 0.0043
596 BLOOD MAGNESIUM DECREASED 37 0.0043
597 BEDRIDDEN 56 0.0043
598 NEOPLASM PROGRESSION 148 0.0043
599 SKIN LESION 116 0.0042
600 UROSEPSIS 39 0.0042
601 PNEUMONIA 1364 0.0042
602 GENERALISED OEDEMA 52 0.0042
603 HYPERGLYCAEMIA 153 0.0042
604 SCHIZOPHRENIA 51 0.0042
605 DRUG WITHDRAWAL SYNDROME NEONATAL 62 0.0042
606 SEXUAL DYSFUNCTION 49 0.0042
607 PHOTOSENSITIVITY REACTION 69 0.0042
608 BONE MARROW FAILURE 84 0.0041
609 MIDDLE INSOMNIA 77 0.0041
610 MICTURITION URGENCY 47 0.0041
611 HYPOGLYCAEMIA 199 0.0041
612 DEVICE RELATED INFECTION 63 0.0041
613 NO ADVERSE EVENT 736 0.0041
614 DECREASED APPETITE 942 0.0041
615 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 194 0.0040
616 MUSCULAR WEAKNESS 459 0.0040
617 PANCREATITIS 213 0.0040
618 BLISTER 226 0.0040
619 EMOTIONAL DISORDER 124 0.0040
620 LYMPHADENOPATHY 142 0.0040
621 LIVER FUNCTION TEST INCREASED 86 0.0040
622 NEUTROPHIL COUNT INCREASED 41 0.0040
623 BLOOD ALKALINE PHOSPHATASE INCREASED 99 0.0040
624 COLITIS 151 0.0040
625 RENAL FAILURE 527 0.0040
626 INABILITY TO AFFORD MEDICATION 39 0.0039
627 ADVERSE DRUG REACTION 352 0.0039
628 INCREASED TENDENCY TO BRUISE 36 0.0039
629 RENAL IMPAIRMENT 327 0.0039
630 PNEUMOCYSTIS JIROVECII PNEUMONIA 39 0.0039
631 HAEMATOCRIT DECREASED 77 0.0039
632 INTERSTITIAL LUNG DISEASE 188 0.0039
633 INTERNATIONAL NORMALISED RATIO INCREASED 110 0.0039
634 HYPERKALAEMIA 135 0.0038
635 CANDIDA INFECTION 65 0.0038
636 HEPATIC ENZYME INCREASED 260 0.0038
637 BLOOD CREATININE INCREASED 249 0.0038
638 RED BLOOD CELL COUNT DECREASED 109 0.0038
639 URINARY TRACT INFECTION 650 0.0038
640 PULMONARY CONGESTION 50 0.0038
641 FOOT DEFORMITY 42 0.0038
642 NEUTROPHIL COUNT DECREASED 154 0.0038
643 BODY TEMPERATURE INCREASED 77 0.0038
644 VERTIGO 230 0.0038
645 FEAR 101 0.0038
646 FACE OEDEMA 63 0.0037
647 INSURANCE ISSUE 57 0.0037
648 RESPIRATORY TRACT INFECTION 97 0.0037
649 ANXIETY 1055 0.0037
650 PLATELET COUNT DECREASED 391 0.0037
651 CARDIOMYOPATHY 54 0.0037
652 BLOOD CALCIUM DECREASED 41 0.0036
653 RASH ERYTHEMATOUS 174 0.0036
654 RESTLESS LEGS SYNDROME 66 0.0036
655 HYPERCHOLESTEROLAEMIA 35 0.0036
656 CHRONIC KIDNEY DISEASE 275 0.0036
657 ROAD TRAFFIC ACCIDENT 151 0.0036
658 GAIT INABILITY 120 0.0036
659 POOR VENOUS ACCESS 37 0.0036
660 DIZZINESS 1783 0.0036
661 BRAIN FOG 56 0.0036
662 EATING DISORDER 76 0.0036
663 TRANSIENT ISCHAEMIC ATTACK 120 0.0036
664 BLOOD LACTATE DEHYDROGENASE INCREASED 56 0.0035
665 ANGIOEDEMA 156 0.0035
666 WITHDRAWAL SYNDROME 148 0.0035
667 ANAEMIA 671 0.0035
668 INSOMNIA 937 0.0035
669 SPLENOMEGALY 41 0.0035
670 CARDIOMEGALY 43 0.0035
671 OSTEOPENIA 53 0.0035
672 PRODUCT PRESCRIBING ISSUE 76 0.0035
673 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 102 0.0035
674 MULTI-ORGAN FAILURE 60 0.0035
675 ARRHYTHMIA 163 0.0034
676 OBSTRUCTIVE AIRWAYS DISORDER 38 0.0034
677 HYPOTHYROIDISM 109 0.0034
678 INITIAL INSOMNIA 35 0.0034
679 NIGHTMARE 118 0.0034
680 LIVER DISORDER 151 0.0034
681 DYSURIA 125 0.0034
682 HEAD DISCOMFORT 60 0.0034
683 DEHYDRATION 449 0.0034
684 DEEP VEIN THROMBOSIS 218 0.0034
685 ERECTILE DYSFUNCTION 86 0.0033
686 PLEURAL EFFUSION 203 0.0033
687 NEURALGIA 81 0.0033
688 JOINT INJURY 71 0.0033
689 NEOPLASM 38 0.0033
690 COVID-19 PNEUMONIA 39 0.0033
691 OEDEMA 179 0.0033
692 CONJUNCTIVITIS 61 0.0033
693 BLOOD UREA INCREASED 55 0.0033
694 HOSPITALISATION 504 0.0033
695 DRUG ABUSE 273 0.0033
696 THYROID DISORDER 50 0.0032
697 PRODUCT USE COMPLAINT 51 0.0032
698 SWOLLEN TONGUE 101 0.0032
699 PHARYNGITIS 40 0.0032
700 GASTROENTERITIS VIRAL 58 0.0032
701 HAEMATURIA 110 0.0032
702 FATIGUE 2500 0.0032
703 ACCIDENT 38 0.0032
704 PALLOR 86 0.0032
705 INTENTIONAL PRODUCT USE ISSUE 276 0.0031
706 WOUND 88 0.0031
707 THERAPEUTIC RESPONSE DECREASED 190 0.0031
708 IMPAIRED QUALITY OF LIFE 45 0.0031
709 MOBILITY DECREASED 224 0.0031
710 DYSSTASIA 91 0.0031
711 WEIGHT DECREASED 869 0.0031
712 FOOT FRACTURE 59 0.0031
713 NERVOUSNESS 162 0.0031
714 HYPERLIPIDAEMIA 37 0.0031
715 VOMITING 1449 0.0031
716 MALIGNANT NEOPLASM PROGRESSION 315 0.0031
717 BLOOD BILIRUBIN INCREASED 83 0.0031
718 FEELING JITTERY 58 0.0030
719 STAPHYLOCOCCAL INFECTION 100 0.0030
720 PRODUCT DOSE OMISSION 197 0.0030
721 MENINGIOMA 47 0.0030
722 EPISTAXIS 225 0.0030
723 MALIGNANT MELANOMA 40 0.0030
724 PRODUCT DISPENSING ERROR 65 0.0030
725 ASTHENIA 1122 0.0030
726 SEASONAL ALLERGY 42 0.0030
727 NEPHROLITHIASIS 136 0.0030
728 ORAL CANDIDIASIS 39 0.0030
729 CEREBROVASCULAR ACCIDENT 495 0.0029
730 RIB FRACTURE 60 0.0029
731 RASH GENERALISED 75 0.0029
732 ANHEDONIA 76 0.0029
733 GASTRITIS 76 0.0029
734 BLOOD TRIGLYCERIDES INCREASED 51 0.0029
735 PULMONARY OEDEMA 129 0.0029
736 SARS-COV-2 TEST POSITIVE 38 0.0029
737 HAEMOGLOBIN DECREASED 295 0.0029
738 WHITE BLOOD CELL COUNT INCREASED 109 0.0028
739 PROTEINURIA 54 0.0028
740 WEIGHT INCREASED 636 0.0028
741 PULMONARY HYPERTENSION 59 0.0028
742 INCREASED APPETITE 54 0.0028
743 BASAL CELL CARCINOMA 44 0.0028
744 CHOKING 55 0.0028
745 RASH 1226 0.0028
746 GASTROENTERITIS 41 0.0028
747 NEUROPATHY PERIPHERAL 267 0.0028
748 UNEVALUABLE EVENT 212 0.0028
749 STOMATITIS 169 0.0028
750 MOUTH ULCERATION 58 0.0027
751 ATRIAL FIBRILLATION 267 0.0027
752 INFECTION 396 0.0027
753 BACTERIAL INFECTION 51 0.0027
754 RASH PRURITIC 148 0.0027
755 LIMB INJURY 74 0.0027
756 HEADACHE 1701 0.0027
757 GINGIVAL BLEEDING 37 0.0027
758 PARAESTHESIA 426 0.0027
759 DRUG EFFECT INCOMPLETE 98 0.0027
760 POLLAKIURIA 112 0.0027
761 RESPIRATORY DISORDER 80 0.0027
762 METASTASES TO LIVER 47 0.0027
763 THERAPY INTERRUPTED 191 0.0027
764 BLOOD POTASSIUM DECREASED 80 0.0027
765 LOWER LIMB FRACTURE 51 0.0027
766 THERAPEUTIC RESPONSE UNEXPECTED 119 0.0026
767 OSTEOPOROSIS 109 0.0026
768 DRUG TOXICITY 36 0.0026
769 RASH PAPULAR 59 0.0026
770 METASTASES TO BONE 43 0.0026
771 DRUG DISPENSING ERROR 40 0.0026
772 UPPER GASTROINTESTINAL HAEMORRHAGE 44 0.0026
773 TASTE DISORDER 53 0.0026
774 UPPER LIMB FRACTURE 52 0.0026
775 MIGRAINE 248 0.0026
776 LYMPHOMA 40 0.0026
777 PNEUMOTHORAX 41 0.0026
778 GASTROINTESTINAL HAEMORRHAGE 216 0.0026
779 ANKLE FRACTURE 40 0.0026
780 WHITE BLOOD CELL COUNT DECREASED 279 0.0026
781 ABNORMAL DREAMS 71 0.0026
782 ABSCESS 41 0.0026
783 CONSTIPATION 560 0.0026
784 VIRAL INFECTION 85 0.0026
785 INFLUENZA LIKE ILLNESS 210 0.0025
786 EXTRAPYRAMIDAL DISORDER 63 0.0025
787 UNDERDOSE 185 0.0025
788 EAR INFECTION 67 0.0025
789 ASCITES 74 0.0025
790 PRODUCTIVE COUGH 120 0.0025
791 SKIN DISCOLOURATION 115 0.0025
792 CHROMATURIA 56 0.0025
793 CYSTITIS 78 0.0024
794 RECTAL HAEMORRHAGE 105 0.0024
795 THERAPY CESSATION 125 0.0024
796 CONTUSION 232 0.0024
797 SKIN FISSURES 47 0.0024
798 FUNGAL INFECTION 80 0.0024
799 POST PROCEDURAL COMPLICATION 46 0.0024
800 DIARRHOEA 1544 0.0024
801 FEMUR FRACTURE 74 0.0024
802 DISABILITY 47 0.0024
803 ECONOMIC PROBLEM 36 0.0024
804 VISION BLURRED 326 0.0024
805 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 55 0.0024
806 BLOOD PRESSURE DECREASED 156 0.0023
807 HAEMATOCHEZIA 129 0.0023
808 RENAL FAILURE ACUTE 99 0.0023
809 UPPER RESPIRATORY TRACT INFECTION 107 0.0023
810 GASTROOESOPHAGEAL REFLUX DISEASE 186 0.0023
811 BLOOD PRESSURE SYSTOLIC INCREASED 45 0.0023
812 HEART RATE DECREASED 81 0.0023
813 MYELOSUPPRESSION 83 0.0023
814 HYPERTENSION 488 0.0023
815 AGEUSIA 57 0.0023
816 CELLULITIS 115 0.0023
817 ANAPHYLACTIC REACTION 126 0.0023
818 CONTRAINDICATED PRODUCT ADMINISTERED 69 0.0023
819 BLOOD POTASSIUM INCREASED 37 0.0023
820 ORAL PAIN 51 0.0023
821 GASTROINTESTINAL DISORDER 202 0.0023
822 ADVERSE EVENT 207 0.0022
823 SPINAL FRACTURE 45 0.0022
824 CARDIAC FAILURE 180 0.0022
825 INTERVERTEBRAL DISC PROTRUSION 49 0.0022
826 OROPHARYNGEAL PAIN 207 0.0022
827 HEPATIC CIRRHOSIS 42 0.0022
828 PULMONARY EMBOLISM 212 0.0022
829 SWELLING FACE 145 0.0022
830 CHILLS 261 0.0022
831 SYSTEMIC LUPUS ERYTHEMATOSUS 79 0.0022
832 LIP SWELLING 74 0.0022
833 RENAL INJURY 66 0.0022
834 LOWER RESPIRATORY TRACT INFECTION 101 0.0022
835 BLOOD URINE PRESENT 42 0.0022
836 IMPAIRED WORK ABILITY 47 0.0022
837 OEDEMA PERIPHERAL 267 0.0022
838 MELAENA 48 0.0022
839 VISUAL ACUITY REDUCED 72 0.0022
840 ABDOMINAL PAIN 502 0.0022
841 LACRIMATION INCREASED 65 0.0021
842 PRODUCT DOSE OMISSION ISSUE 630 0.0021
843 LIMB DISCOMFORT 66 0.0021
844 PAIN IN JAW 60 0.0021
845 HAEMOPTYSIS 59 0.0021
846 FEELING ABNORMAL 506 0.0021
847 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 36 0.0021
848 ABDOMINAL DISTENSION 218 0.0021
849 NAUSEA 1644 0.0021
850 HYPOAESTHESIA 310 0.0021
851 RETCHING 44 0.0021
852 HEART RATE INCREASED 203 0.0020
853 INTESTINAL OBSTRUCTION 77 0.0020
854 BLINDNESS 83 0.0020
855 FULL BLOOD COUNT DECREASED 41 0.0020
856 HIP FRACTURE 65 0.0020
857 LUNG DISORDER 99 0.0020
858 MULTIPLE SCLEROSIS RELAPSE 138 0.0020
859 COUGH 559 0.0020
860 VISUAL IMPAIRMENT 247 0.0020
861 BLOOD PRESSURE INCREASED 303 0.0020
862 DYSPHONIA 115 0.0020
863 INTENTIONAL DOSE OMISSION 56 0.0020
864 ERYTHEMA 402 0.0020
865 PERITONITIS 40 0.0019
866 MUSCULOSKELETAL STIFFNESS 169 0.0019
867 SURGERY 113 0.0019
868 EAR PAIN 37 0.0019
869 CARDIOVASCULAR DISORDER 48 0.0019
870 CHOLELITHIASIS 62 0.0019
871 HYPERSENSITIVITY 350 0.0019
872 INFLUENZA 210 0.0019
873 PERIPHERAL SWELLING 290 0.0019
874 ALOPECIA 369 0.0019
875 HYPERHIDROSIS 242 0.0019
876 BLOOD PRESSURE FLUCTUATION 45 0.0019
877 GLAUCOMA 36 0.0019
878 HAEMORRHAGE 195 0.0019
879 COVID-19 327 0.0019
880 ECZEMA 97 0.0019
881 NECK PAIN 103 0.0018
882 MULTIPLE SCLEROSIS 88 0.0018
883 PRODUCT DOSE OMISSION IN ERROR 52 0.0018
884 DIABETIC KETOACIDOSIS 44 0.0018
885 DEATH 1577 0.0018
886 CHEST PAIN 339 0.0018
887 TINNITUS 84 0.0018
888 MUSCLE SPASMS 335 0.0018
889 FIBROMYALGIA 44 0.0018
890 CATARACT 107 0.0018
891 HAEMORRHOIDS 35 0.0018
892 SKIN ULCER 46 0.0018
893 EYE SWELLING 66 0.0018
894 RASH MACULAR 62 0.0018
895 DERMATITIS 37 0.0018
896 THERAPEUTIC PRODUCT EFFECT DECREASED 78 0.0017
897 HERPES ZOSTER 100 0.0017
898 BRONCHITIS 128 0.0017
899 MALAISE 757 0.0017
900 HYPOACUSIS 73 0.0017
901 RENAL DISORDER 79 0.0017
902 LABORATORY TEST ABNORMAL 50 0.0017
903 BACK PAIN 393 0.0017
904 ILLNESS 174 0.0017
905 PRESYNCOPE 41 0.0017
906 EYE DISORDER 55 0.0017
907 URTICARIA 278 0.0017
908 SKIN EXFOLIATION 140 0.0017
909 SKIN DISORDER 55 0.0016
910 PALPITATIONS 192 0.0016
911 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 85 0.0016
912 THROMBOSIS 131 0.0016
913 ABASIA 40 0.0016
914 MYALGIA 274 0.0016
915 DYSPEPSIA 158 0.0016
916 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 289 0.0016
917 DYSPNOEA EXERTIONAL 60 0.0016
918 DIABETES MELLITUS 121 0.0016
919 INFLAMMATION 81 0.0016
920 INFUSION RELATED REACTION 103 0.0016
921 WHEEZING 92 0.0015
922 INJURY 109 0.0015
923 PRURITUS 594 0.0015
924 TYPE 2 DIABETES MELLITUS 52 0.0015
925 BLOOD CHOLESTEROL INCREASED 72 0.0015
926 GASTRIC DISORDER 53 0.0015
927 ABDOMINAL PAIN LOWER 39 0.0015
928 MUSCULOSKELETAL PAIN 80 0.0015
929 DYSPNOEA 863 0.0015
930 ANGINA PECTORIS 42 0.0015
931 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 102 0.0014
932 ACUTE MYOCARDIAL INFARCTION 42 0.0014
933 TARDIVE DYSKINESIA 40 0.0014
934 RHINORRHOEA 91 0.0014
935 PAIN IN EXTREMITY 412 0.0014
936 CARDIAC DISORDER 130 0.0014
937 ABDOMINAL PAIN UPPER 286 0.0014
938 PLASMA CELL MYELOMA 54 0.0014
939 FLATULENCE 78 0.0014
940 DIVERTICULITIS 38 0.0014
941 SWELLING 128 0.0014
942 NASOPHARYNGITIS 250 0.0014
943 DRUG WITHDRAWAL SYNDROME 119 0.0014
944 DRY MOUTH 109 0.0013
945 EYE PAIN 74 0.0013
946 DRUG ADMINISTRATION ERROR 40 0.0013
947 PAIN 800 0.0013
948 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 257 0.0013
949 ABDOMINAL DISCOMFORT 211 0.0013
950 INCORRECT DOSE ADMINISTERED 287 0.0013
951 FEELING COLD 35 0.0013
952 LUNG NEOPLASM MALIGNANT 51 0.0012
953 FLUID RETENTION 63 0.0012
954 BLOOD GLUCOSE DECREASED 59 0.0012
955 BONE PAIN 71 0.0012
956 JOINT SWELLING 145 0.0012
957 DISCOMFORT 73 0.0012
958 DYSGEUSIA 88 0.0012
959 OCULAR HYPERAEMIA 55 0.0012
960 ARTHRALGIA 476 0.0011
961 VAGINAL HAEMORRHAGE 49 0.0011
962 DRUG DOSE OMISSION 186 0.0011
963 IMPAIRED HEALING 36 0.0011
964 DRUG EFFECT DECREASED 59 0.0011
965 CHEST DISCOMFORT 112 0.0011
966 SINUSITIS 109 0.0011
967 ILL-DEFINED DISORDER 64 0.0011
968 PRODUCT QUALITY ISSUE 142 0.0010
969 ACNE 79 0.0010
970 OSTEOARTHRITIS 44 0.0010
971 FLUSHING 104 0.0010
972 NASAL CONGESTION 60 0.0010
973 FEELING HOT 62 0.0010
974 MYOCARDIAL INFARCTION 176 0.0010
975 DRY EYE 50 0.0010
976 DRY SKIN 131 0.0010
977 BLOOD GLUCOSE INCREASED 183 0.0010
978 NEOPLASM MALIGNANT 63 0.0009
979 EMOTIONAL DISTRESS 112 0.0009
980 THROAT IRRITATION 41 0.0009
981 ASTHMA 103 0.0009
982 HOT FLUSH 67 0.0009
983 BURNING SENSATION 59 0.0008
984 ARTHRITIS 62 0.0008
985 CARDIAC FAILURE CONGESTIVE 63 0.0008
986 ARTHROPATHY 43 0.0008
987 DRUG DEPENDENCE 106 0.0007
988 PSORIASIS 78 0.0006
989 BREAST CANCER 42 0.0005
990 ACCIDENTAL EXPOSURE TO PRODUCT 46 0.0004
991 DEVICE ISSUE 38 0.0004
992 RHEUMATOID ARTHRITIS 38 0.0003
993 INJECTION SITE PAIN 99 0.0003
994 INJECTION SITE ERYTHEMA 39 0.0003